CLICK HERE FOR UTIDX™

Phone: 800-959-2846|Fax: 949-418-7287

  • Home
  • About Us
    • Our Team
    • News
    • Licensure
    • Careers
  • Services
    • Bladder17™
    • UTIDX™
    • Urology
    • Gastroenterology
  • Client Portal
  • Payors
  • Education
    • Videos
    • Clinician Resource
  • Info
    • Contact Us
    • Supplies
    • Pay Your Bill
    • Methodology
  • More
    • Home
    • About Us
      • Our Team
      • News
      • Licensure
      • Careers
    • Services
      • Bladder17™
      • UTIDX™
      • Urology
      • Gastroenterology
    • Client Portal
    • Payors
    • Education
      • Videos
      • Clinician Resource
    • Info
      • Contact Us
      • Supplies
      • Pay Your Bill
      • Methodology

Phone: 800-959-2846|Fax: 949-418-7287

  • Home
  • About Us
    • Our Team
    • News
    • Licensure
    • Careers
  • Services
    • Bladder17™
    • UTIDX™
    • Urology
    • Gastroenterology
  • Client Portal
  • Payors
  • Education
    • Videos
    • Clinician Resource
  • Info
    • Contact Us
    • Supplies
    • Pay Your Bill
    • Methodology

Bladder17™

Developing the most sensitive and specific bladder cancer test

Brochure

About the Bladder17™ bladder cancer test

 Bladder cancer is one of the major cancers of the urinary system that is one of the most expensive cancers to treat due to a high recurrence rate.

Typically, routine monitoring of bladder cancer is performed by cystoscopic examination and is invasive, painful, and expensive. Cystoscopy is often augmented by a non-invasive laboratory method such as urine cytology. However, these tests lack adequate sensitivity or specificity to significantly improve the diagnosis and treatment of bladder cancer patients, 

Find Out More (Patients)Find Out More (PHysicians)

Copyright © 2022 EmeritusDX - All Rights Reserved.

  • Privacy Notice
  • Healthcare Disclaimer

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept